Miscasting Patent Linkage

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. In what can only be described as a slow news period for pharma IP policy, the arcane yet important issue of patent linkage has resurfaced in not once but […]

Forecasting new product revenues

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Forecasting new product revenues
Go to paperABSTRACT: This paper discusses real-life experiences in developing revenue forecasts for biopharmaceutical clien…

Get email updates

Get new actionable insights and updates from BiotechBlog

Do NOT follow this link or you will be banned from the site!